French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GC, Nespeca M, Gidal B, Marks WJ, Turk MR, Fischer JH, Bourgeois B, Wilner A, Faught RE, Sachdeo RC, Beydoun A, Glauser TA: Efficacy and tolerability of the new antiepileptic drugs in treatment of new onset epilepsy: report of the therapeutics and technology assessment subcommittee and quality standards subcommittee of the American academy of neurology and the American epilepsy society. Neurology. 2004, 62: 1252-60.
Article
CAS
PubMed
Google Scholar
National Collaborating Centre for Primary Care: The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care – NICE guideline. 2004, London: National Institute for Clinical Excellence
Google Scholar
Commission on antiepileptic drugs: Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy. Epilepsia. 1998, 39: 799-803. 10.1111/j.1528-1157.1998.tb01167.x.
Article
Google Scholar
Chadwick D: Better comparisons of antiepileptic drugs: what measures of efficacy?. Pharm World Sci. 1997, 19: 214-216. 10.1023/A:1008642623460.
Article
CAS
PubMed
Google Scholar
Perucca E: Evaluation of drug treatment outcome in epilepsy: a clinical perspective. Pharm World Sci. 1997, 19: 217-222. 10.1023/A:1008698807530.
Article
CAS
PubMed
Google Scholar
Kalbfleisch JD, Prentice RL: The statistical analysis of failure time data. 1980, Wiley, New York
Google Scholar
Marson AG, Williamson PR, Hutton JL, Clough HE, Chadwick DW: Carbamazepine versus valproate monotherapy for epilepsy (Cochrane Review). The Cochrane Library. 2000, Oxford: Update Software, 3
Google Scholar
Taylor S, Tudur Smith C, Williamson PR, Marson AG: Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalized onset tonic-clonic seizures (Cochrane Review). The Cochrane Library. 2001, Oxford: Update Software, 4
Google Scholar
Tudur Smith C, Marson AG, Williamson PR: Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures (Cochrane Review). The Cochrane Library. 2001, Oxford: Update Software, 4
Google Scholar
Tudur Smith C, Marson AG, Clough HE, Williamson PR: Carbamazepine versus phenytoin monotherapy for epilepsy (Cochrane Review). The Cochrane Library. 2002, Oxford: Update Software, 2
Google Scholar
Tudur Smith C, Marson AG, Williamson PR: Carbamazepine versus phenobarbitone monotherapy for epilepsy (Cochrane Review). The Cochrane Library. 2003, Oxford: Update Software, 1
Google Scholar
Gamble CL, Marson AG, Williamson PR: Lamotrigine versus carbamazepine monotherapy for epilepsy (Protocol for a Cochrane Review). The Cochrane Library. 2004, Oxford: Update Software, 2
Google Scholar
Muller MM, Marson AG, Williamson PR: Oxcarbazepine versus phenytoin monotherapy for epilepsy (Protocol for a Cochrane Review). The Cochrane Library. 2004, Oxford: Update Software, 2
Google Scholar
Tudur Smith C, Marson AG, Williamson PR: Valproate versus phenobarbitone monotherapy for epilepsy [Cochrane protocol]. The Cochrane Library. 2004, Oxford: Update Software, 1
Google Scholar
Lhatoo SD, Wong ICK, Polizzi G, Sander JWAS: Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy. Epilepsia. 2000, 41: 1592-1596. 10.1111/j.1528-1157.2000.tb00165.x.
Article
CAS
PubMed
Google Scholar
Lhatoo SD, Wong ICK, Sander JWAS: Prognostic factors affecting long-term retention of topiramate in patients with chronic epilepsy. Epilepsia. 2000, 41: 338-341. 10.1111/j.1528-1157.2000.tb00165.x.
Article
CAS
PubMed
Google Scholar
Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, Cockerell OC, Cooper PN, Doughty J, Eaton B, Gamble C, Goulding PJ, Howell SJL, Hughes A, Jackson M, Jacoby A, Kellett M, Lawson GR, Leach JP, Nicolaides P, Roberts R, Shackley P, Shen J, Smith DF, Smith PEM, Tudur Smith C, Vanoli A, Williamson PR, on behalf of the SANAD Study group: Carbamazepine, gabapentin, lamotrigine, oxcarbazepine or topiramate for partial epilepsy: results from the SANAD trial. Lancet.
Heller AJ, Chesterman P, Elwes RD, Crawford P, Chadwick D, Johnson AL, Reynolds EH: Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial. JNNP. 1995, 58: 44-50.
CAS
Google Scholar
de Silva M, MacArdle B, McGowan M, Hughes E, Stewart J, Reynolds EH, Hughes E, Neville BGR, Johnson AL: Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy. The Lancet. 1996, 347: 709-13. 10.1016/S0140-6736(96)90074-4.
Article
CAS
Google Scholar
Mattson RH, Cramer JA, Collins JF, Smith DB, Delgado-Escueta AV, Browne TR, Williamson PD, Treiman DM, McNamara JO, McCutchen CB, Homan RW, Crill WE, Lubozynski MF, Rosenthal NP, Mayersdorf A: Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. NEJM. 1985, 313: 145-51.
Article
CAS
PubMed
Google Scholar
Mattson RH, Cramer JA, Collins JF: A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. NEJM. 1992, 327: 765-71.
Article
CAS
PubMed
Google Scholar
Richens A, Davidson DLW, Cartlidge NEF, Easter DJ: A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. JNNP. 1994, 57: 682-687.
CAS
Google Scholar
Verity CM, Hosking G, Easter DJ: A multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy. Dev Med Child Neur. 1995, 37: 97-108.
Article
CAS
Google Scholar
Brodie MJ, Richens A, Yuen AWC: Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. The Lancet. 1995, 345: 476-79. 10.1016/S0140-6736(95)90581-2.
Article
CAS
Google Scholar
Ramsey RE, Wilder BJ, Murphy JV, Holmes GL, Uthman B: Efficacy and safety of valproic acid versus phenytoin as sole therapy for newly diagnosed primary generalized tonic-clonic seizures. Epilepsy. 1992, 5: 55-60. 10.1016/S0896-6974(05)80021-0.
Article
Google Scholar
Turnbull DM, Howel D, Rawlins MD, Chadwick DW: Which drug for the adult epileptic patient: phenytoin or valproate?. BMJ. 1985, 290: 815-819.
Article
CAS
PubMed
PubMed Central
Google Scholar
Placencia M, Sander JWAS, Shorvon SD, Roman M, Alarcon F, Bimos C, Cascante S: Antiepileptic drug treatment in a community health care setting in northern Ecuador: a prospective 12-month assessment. Epilepsy Res. 1993, 14: 237-244. 10.1016/0920-1211(93)90048-C.
Article
CAS
PubMed
Google Scholar
Brodie MJ, Overstall PW, Giorgi L: Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsy Res. 1999, 37: 81-87. 10.1016/S0920-1211(99)00039-X.
Article
CAS
PubMed
Google Scholar
Bill PA, Vigonius U, Pohlmann H, Guerreiro CA, Kochen S, Saffer D, Moore A: A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy. Epilepsy Res. 1997, 27: 195-204. 10.1016/S0920-1211(97)00024-7.
Article
CAS
PubMed
Google Scholar
Guerreiro MM, Vigonius U, Pohlmann H, de Manreza ML, Fejerman N, Antoniuk SA, Moore A: A double-blind controlled trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Res. 1997, 27: 205-213. 10.1016/S0920-1211(97)00025-9.
Article
CAS
PubMed
Google Scholar
Nieto-Barrera M, Brozmanova M, Capovilla G, Christe W, Pedersen B, Kane K, O'Neill F: A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy. Epilepsy Res. 2001, 46: 145-155. 10.1016/S0920-1211(01)00271-6.
Article
CAS
PubMed
Google Scholar
Gray RJ: Subdistribution analysis of competing risks. Version 2.1–5. 2004, http://www.r-project.org
Google Scholar
Williamson PR, Kolamnunnage-Dona R, Tudur Smith C: The influence of competing risks setting on the choice of hypothesis test for treatment effect. Biostatistics. 2006, doi: 10.1093/biostatistics/kxl040
Google Scholar